Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial-Reference-Cited by-同舟云学术

Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial

Published:2008-04-07 Issue:5 Volume:10 Page:528-535
ISSN:1099-5129
Container-title:Europace
language:en
Short-container-title:Europace

Author:

Almendral J.,Arribas F.,Wolpert C.,Ricci R.,Adragao P.,Cobo E.,Navarro X.,Quesada A.,

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/10/5/528/7532606/eun072.pdf

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single‐ Versus Dual‐Chamber Implantable Cardioverter‐Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States;Journal of the American Heart Association;2023-08

2. Implantable Cardioverter-Defibrillator for Primary Prevention in Asia;JACC: Asia;2023-06

3. DX single-lead implantable cardioverter-defibrillator system with a floating atrial dipole: when, to whom, and why?;Russian Journal of Cardiology;2023-04-21

4. The efficacy of single-lead implantable cardioverter-defibrillator with atrial sensing dipole to detect atrial fibrillation and to reduce inappropriate therapy according to atrial sensing ON or OFF: Rationale and design of the SMART-CONTROL study, a prospective multicenter randomized trial;American Heart Journal;2022-09

5. Successful Identification of and Discrimination Between Atrial and Ventricular Arrhythmia with the Aid of Pacing and Defibrillator Devices;Arrhythmia & Electrophysiology Review;2021-12-15